Commonwealth Equity Services, LLC Denali Therapeutics Inc. Transaction History

Commonwealth Equity Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$29.0 - $47.27 $134,444 - $219,143	-4,636 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$42.59 - $55.02 $20,102 - $25,969	472 Added 11.34%	4,636 $206,000
Q3 2021 Oct 29, 2021	BUY	$48.48 - $78.23 $9,453 - $15,254	195 Added 4.91%	4,164 $210,000
Q4 2020 Feb 11, 2021	BUY	$36.89 - $93.56 $146,416 - $371,339	3,969 New	3,969 $332,000

240

121M

80K

36.8K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.92B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.